Trial Profile
Phase I Clinical Trial of Nasal Spray in Treating Patients With Recurrent Glioblastoma, Gliosarcoma, Glioma
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase I
Latest Information Update: 26 Jul 2018
Price :
$35
*
At a glance
- Drugs Axitinib (Primary) ; Pazopanib (Primary) ; Sunitinib (Primary)
- Indications Glioblastoma; Glioma; Gliosarcoma
- Focus Therapeutic Use
- 17 Jul 2018 Planned End Date changed from 1 Nov 2019 to 19 Jul 2018.
- 17 Jul 2018 Planned primary completion date changed from 1 Nov 2018 to 18 Jul 2018.
- 17 Jul 2018 Planned initiation date changed from 1 Feb 2018 to 17 Jul 2018.